BLAKE KOCEJA: Open Payments
NPI 1205585874 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,187 in 133 payments from 40 companies in 2025. Trend: 2023 $1,005 · 2024 $3,700 · 2025 $3,187
Food & beverage: $3,087Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $303 |
| Merck Sharp & Dohme LLC | 9 | $264 |
| Janssen Biotech, Inc. | 10 | $259 |
| Incyte Corporation | 6 | $224 |
| ABBVIE INC. | 7 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $142 |
| Eisai Inc. | 5 | $133 |
| AstraZeneca Pharmaceuticals LP | 5 | $120 |
| Genentech USA, Inc. | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
Products named: KEYTRUDA, KISQALI, Lenvima, RYBREVANT, Nubeqa, ERLEADA, EPKINLY, DANZITEN.
Industry payments across SC — which companies pay providers there.
